ADMA Biologics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 38.15 M | $654.27 M | -0.31% | 16.26% |
VANGUARD GROUP INC | 02/11/2025 | 18.20 M | $312.11 M | 0.44% | 7.76% |
STATE STREET CORP | 02/14/2025 | 14.87 M | $255.03 M | 14.35% | 6.34% |
INVESCO LTD. | 02/13/2025 | 11.30 M | $193.73 M | -10.49% | 4.82% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 5.43 M | $93.19 M | 0.94% | 2.32% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 4.67 M | $80.07 M | 15.99% | 1.99% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 4.55 M | $78.07 M | -30.79% | 1.94% |
DEUTSCHE BANK AG\ | 02/14/2025 | 3.88 M | $66.47 M | -6.20% | 1.65% |
AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 3.77 M | $64.72 M | -10.36% | 1.61% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 3.77 M | $64.65 M | 2.80% | 1.61% |
PERPETUAL LTD | 01/17/2025 | 3.63 M | $62.30 M | 100.00% | 1.55% |
OBERWEIS ASSET MANAGEMENT INC/ | 02/14/2025 | 3.34 M | $57.32 M | 14.98% | 1.43% |
FMR LLC | 02/13/2025 | 3.20 M | $54.84 M | 64.42% | 1.36% |
D. E. SHAW & CO., INC. | 02/14/2025 | 3.07 M | $52.59 M | -41.75% | 1.31% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 2.95 M | $50.59 M | -33.77% | 1.26% |
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 01/29/2025 | 2.84 M | $51.02 M | 1,144.42% | 1.21% |
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/12/2025 | 2.76 M | $47.38 M | 57.94% | 1.18% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 2.70 M | $46.28 M | 3.33% | 1.15% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 2.55 M | $43.71 M | -29.03% | 1.09% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 2.44 M | $41.85 M | 1.61% | 1.04% |
AWM INVESTMENT COMPANY, INC. | 02/18/2025 | 2.43 M | $41.61 M | -45.51% | 1.03% |
02/14/2025 | 2.29 M | $39.23 M | 100.00% | 0.98% | |
LORD, ABBETT & CO. LLC | 02/14/2025 | 2.21 M | $37.86 M | -28.67% | 0.94% |
PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 2.10 M | $36.03 M | 0.02% | 0.90% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 1.52 M | $26.09 M | 10.76% | 0.65% |
ALTIUM CAPITAL MANAGEMENT LP | 02/13/2025 | 1.40 M | $23.92 M | 2.57% | 0.59% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.37 M | $23.52 M | -33.30% | 0.58% |
OPHIR ASSET MANAGEMENT PTY LTD | 02/14/2025 | 1.34 M | $23.01 M | 75.84% | 0.57% |
FEDERATED HERMES, INC. | 02/13/2025 | 1.31 M | $22.41 M | -19.71% | 0.56% |
PRINCIPAL FINANCIAL GROUP INC | 01/31/2025 | 1.26 M | $21.59 M | 5.43% | 0.54% |
STONEPINE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 1.24 M | $21.28 M | -33.63% | 0.53% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 1.16 M | $19.89 M | 3.81% | 0.49% |
RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 1.11 M | $19.08 M | 100.00% | 0.47% |
MACQUARIE GROUP LTD | 02/14/2025 | 1.01 M | $17.40 M | -10.86% | 0.43% |
UBS GROUP AG | 02/14/2025 | 1.00 M | $17.22 M | 140.34% | 0.43% |
CITIGROUP INC | 02/12/2025 | 942,183 | $16.16 M | 143.32% | 0.40% |
VOYA INVESTMENT MANAGEMENT LLC | 02/14/2025 | 918,361 | $15.75 M | 46.77% | 0.39% |
PERCEPTIVE ADVISORS LLC | 02/14/2025 | 890,280 | $15.27 M | -16.03% | 0.38% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 881,000 | $15.11 M | 55.27% | 0.38% |
LEGAL & GENERAL GROUP PLC | 02/13/2025 | 836,850 | $14.35 M | 20.06% | 0.36% |
MESIROW INSTITUTIONAL INVESTMENT MANAGEMENT, INC. | 02/13/2025 | 782,451 | $13.42 M | -21.90% | 0.33% |
JPMORGAN CHASE & CO | 02/12/2025 | 767,265 | $13.16 M | 272.54% | 0.33% |
MAN GROUP PLC | 02/14/2025 | 745,300 | $12.78 M | 305.51% | 0.32% |
AMERIPRISE FINANCIAL INC | 02/14/2025 | 715,672 | $12.27 M | 14.12% | 0.31% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 686,900 | $11.78 M | 1,486.37% | 0.29% |
FIRST TURN MANAGEMENT, LLC | 02/14/2025 | 684,230 | $11.73 M | 2.89% | 0.29% |
RUSSELL INVESTMENTS GROUP, LTD. | 02/13/2025 | 646,009 | $11.08 M | -20.05% | 0.28% |
RHUMBLINE ADVISERS | 01/30/2025 | 621,079 | $10.65 M | 0.96% | 0.26% |
QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 602,767 | $10.34 M | 95.65% | 0.26% |
ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 591,679 | $10.15 M | -82.97% | 0.25% |
ADMA Biologics, Inc. institutional Ownership - FAQ's
During the previous two years, 391 institutional investors and hedge funds held shares of ADMA Biologics, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 38.15 M
VANGUARD GROUP INC: 18.2 M
STATE STREET CORP: 14.87 M
Invesco Ltd.: 11.3 M
GEODE CAPITAL MANAGEMENT, LLC: 5.43 M
DIMENSIONAL FUND ADVISORS LP: 4.67 M
86.90% of ADMA Biologics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 229.94 M shares in the last 24 months. This purchase volume represents approximately $4.40 B in transactions.